Chk1 modulates the interaction between myosin phosphatase targeting protein 1 (MYPT1) and protein phosphatase 1cβ (PP1cβ)

References

• Zitouni S, Nabais C, Jana SC, et al. Polo-like kinases: structural variations lead to multiple functions. Nat Rev Mol Cell Biol. 2014;15:433–452. doi:10.1038/nrm3819. PMID:24954208
   PubMed Web of Science ®Google Scholar
• Seki A, Coppinger JA, Jang CY, et al. Bora and the kinase Aurora A cooperatively activate the kinase Plk1 and control mitotic entry. Science. 2008;320:1655–1658. doi:10.1126/science.1157425. PMID:18566290
   PubMed Web of Science ®Google Scholar
• Bruinsma W, Macurek L, Freire R, et al. Bora and Aurora-A continue to activate Plk1 in mitosis. J Cell Sci. 2014;127:801–811. doi:10.1242/jcs.137216. PMID:24338364
   PubMed Web of Science ®Google Scholar
• Bruinsma W, Aprelia M, Garcia-Santisteban I, et al. Inhibition of Polo-like kinase 1 during the DNA damage response is mediated through loss of Aurora A recruitment by Bora. Oncogene. 2017;36:1840–1848. doi:10.1038/onc.2016.347. PMID:27721411
   PubMed Web of Science ®Google Scholar
• Smits VA, Klompmaker R, Arnaud L, et al. Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol. 2000;2:672–676. doi:10.1038/35023629. PMID:10980711
   PubMed Web of Science ®Google Scholar
• van Vugt MA, Smits VA, Klompmaker R, et al. Inhibition of Polo-like kinase-1 by DNA damage occurs in an ATM- or ATR-dependent fashion. J Biol Chem. 2001;276:41656–41660. doi:10.1074/jbc.M101831200. PMID:11514540
   PubMed Web of Science ®Google Scholar
• Tang J, Erikson RL, Liu X. Checkpoint kinase 1 (Chk1) is required for mitotic progression through negative regulation of polo-like kinase 1 (Plk1). Proc Natl Acad Sci U S A. 2006;103:11964–11969. doi:10.1073/pnas.0604987103. PMID:16873548
   PubMed Web of Science ®Google Scholar
• Bassermann F, Frescas D, Guardavaccaro D, et al. The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint. Cell. 2008;134:256–267. doi:10.1016/j.cell.2008.05.043. PMID:18662541
   PubMed Web of Science ®Google Scholar
• Li Z, Li J, Kong Y, et al. Plk1 Phosphorylation of Mre11 Antagonizes the DNA Damage Response. Cancer Res. 2017;77:3169–3180. doi:10.1158/0008-5472.CAN-16-2787. PMID:28512243
   PubMed Web of Science ®Google Scholar
• Shao C, Chien SJ, Farah E, et al. Plk1 phosphorylation of Numb leads to impaired DNA damage response. Oncogene. 2017. doi:10.1038/onc.2017.379.
   Web of Science ®Google Scholar
• Zhao H, Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol. 2001;21:4129–4139. doi:10.1128/MCB.21.13.4129-4139.2001. PMID:11390642
   PubMed Web of Science ®Google Scholar
• Jazayeri A, Falck J, Lukas C, et al. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol. 2006;8:37–45. doi:10.1038/ncb1337. PMID:16327781
   PubMed Web of Science ®Google Scholar
• Smith J, Tho LM, Xu N, et al. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res. 2010;108:73–112. doi:10.1016/B978-0-12-380888-2.00003-0. PMID:21034966
   PubMed Web of Science ®Google Scholar
• Zachos G, Black EJ, Walker M, et al. Chk1 is required for spindle checkpoint function. Dev Cell. 2007;12:247–260. doi:10.1016/j.devcel.2007.01.003. PMID:17276342
   PubMed Web of Science ®Google Scholar
• Carrassa L, Damia G. Unleashing Chk1 in cancer therapy. Cell Cycle. 2011;10:2121–2128. doi:10.4161/cc.10.13.16398. PMID:21610326
   PubMed Web of Science ®Google Scholar
• Grassie ME, Moffat LD, Walsh MP, et al. The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1delta. Arch Biochem Biophys. 2011;510:147–159. doi:10.1016/j.abb.2011.01.018. PMID:21291858
   PubMed Web of Science ®Google Scholar
• Ito M, Nakano T, Erdodi F, et al. Myosin phosphatase: structure, regulation and function. Mol Cell Biochem. 2004;259:197–209. doi:10.1023/B:MCBI.0000021373.14288.00. PMID:15124925
   PubMed Web of Science ®Google Scholar
• Kuntziger T, Landsverk HB, Collas P, et al. Protein phosphatase 1 regulators in DNA damage signaling. Cell Cycle. 2011;10:1356–1362. doi:10.4161/cc.10.9.15442. PMID:21451260
   PubMed Web of Science ®Google Scholar
• Yamashiro S, Yamakita Y, Totsukawa G, et al. Myosin phosphatase-targeting subunit 1 regulates mitosis by antagonizing polo-like kinase 1. Dev Cell. 2008;14:787–797. doi:10.1016/j.devcel.2008.02.013. PMID:18477460
   PubMed Web of Science ®Google Scholar
• Chiyoda T, Sugiyama N, Shimizu T, et al. LATS1/WARTS phosphorylates MYPT1 to counteract PLK1 and regulate mammalian mitotic progression. J Cell Biol. 2012;197:625–641. doi:10.1083/jcb.201110110. PMID:22641346
   PubMed Web of Science ®Google Scholar
• Kachaner D, Filipe J, Laplantine E, et al. Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression. Mol Cell. 2012;45:553–566. doi:10.1016/j.molcel.2011.12.030. PMID:22365832
   PubMed Web of Science ®Google Scholar
• Li Z, Li X, Nai S, et al. Checkpoint kinase 1-induced phosphorylation of O-linked beta-N-acetylglucosamine transferase regulates the intermediate filament network during cytokinesis. J Biol Chem. 2017;292(48):19548–19555. doi:10.1074/jbc.M117.811646.
   PubMed Web of Science ®Google Scholar
• Smith SC, Petrova AV, Madden MZ, et al. A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response. Nucleic Acids Res. 2014;42:11517–11527. doi:10.1093/nar/gku840. PMID:25217585
   PubMed Web of Science ®Google Scholar
• Twomey E, Li Y, Lei J, et al. Regulation of MYPT1 stability by the E3 ubiquitin ligase SIAH2. Exp Cell Res. 2010;316:68–77. doi:10.1016/j.yexcr.2009.09.001. PMID:19744480
   PubMed Web of Science ®Google Scholar
• Chao A, Zhang X, Ma D, et al. Site-specific phosphorylation of protein phosphatase 1 regulatory subunit 12A stimulated or suppressed by insulin. J Proteomics. 2012;75:3342–3350. doi:10.1016/j.jprot.2012.03.043. PMID:22516431
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1. doi:10.1126/scisignal.2004088. PMID:23550210
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401–404. doi:10.1158/2159-8290.CD-12-0095. PMID:22588877
   PubMed Web of Science ®Google Scholar
• Hong J, Hu K, Yuan Y, et al. CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma. J Clin Invest. 2012;122:2165–2175. doi:10.1172/JCI61380. PMID:22585575
   PubMed Web of Science ®Google Scholar
• Kang T, Wei Y, Honaker Y, et al. GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell. 2008;13:36–47. doi:10.1016/j.ccr.2007.12.002. PMID:18167338
   PubMed Web of Science ®Google Scholar
• Matsumura F, Hartshorne DJ. Myosin phosphatase target subunit: Many roles in cell function. Biochem Biophys Res Commun. 2008;369:149–156. doi:10.1016/j.bbrc.2007.12.090. PMID:18155661
   PubMed Web of Science ®Google Scholar
• Li J, Liu X, Liao J, et al. MYPT1 sustains centromeric cohesion and the spindle-assembly checkpoint. J Genet Genomics. 2013;40:575–578. doi:10.1016/j.jgg.2013.08.005. PMID:24238611
   PubMed Web of Science ®Google Scholar
• Li J, Wang J, Hou W, et al. Phosphorylation of Ataxin-10 by polo-like kinase 1 is required for cytokinesis. Cell Cycle. 2011;10:2946–2958. doi:10.4161/cc.10.17.15922. PMID:21857149
   PubMed Web of Science ®Google Scholar
• Tian J, Tian C, Ding Y, et al. Aurora B-dependent phosphorylation of Ataxin-10 promotes the interaction between Ataxin-10 and Plk1 in cytokinesis. Sci Rep. 2015;5:8360. doi:10.1038/srep08360. PMID:25666058
   PubMed Web of Science ®Google Scholar